Showing 87 of 87on this page. Filters & sort apply to loaded results; URL updates for sharing.87 of 87 on this page
Capmatinib cancer drug molecule (c-met inhibitor). Stylized skeletal ...
Capmatinib cancer drug molecule (c-met inhibitor). Skeletal formula ...
Capmatinib molecule flat skeletal structure, Tyrosine kinase - EGFR ...
Capmatinib is an Orally Active c-Met Kinase Inhibitor for NSCLC ...
A Rapid and Sensitive UPLC-MS/MS Method for Quantifying Capmatinib in ...
Capmatinib cancer drug molecule (c-met inhibitor). 3D rendering. Atoms ...
Capmatinib （INCB28060）| 卡马替尼 | c-Met抑制剂 | 抗肿瘤 | TargetMol
Capmatinib cancer drug molecule hi-res stock photography and images - Alamy
Capmatinib cancer drug molecule (c-met inhibitor). 3D rendering Stock ...
Capmatinib chemical structure. | Download Scientific Diagram
Capmatinib metabolite M19 | C23H17FN6O2 | CID 154585062 - PubChem
Capmatinib metabolite M16 | C23H17FN6O2 | CID 154584796 - PubChem
The Development and Role of Capmatinib in the Treatment of MET ...
MET Inhibitor Capmatinib Radiosensitizes MET Exon 14-Mutated and MET ...
Synthesis of Capmatinib Dihydrocholride_Chemicalbook
Capmatinib in MET exon 14-mutated non-small-cell lung cancer: final ...
Combined treatment with capmatinib and afatinib effectively inhibited ...
EP08.02-122 Real-world Experience with Capmatinib in MET Exon 14 ...
Figure 1 from Profile of Capmatinib for the Treatment of Metastatic Non ...
Capmatinib in MET Exon 14–Mutated or MET-Amplified Non–Small-Cell Lung ...
Buy Capmatinib | 1029712-80-8 | Novapure Healthcare
A Phase 2 Study of Capmatinib in Patients With MET-Altered Lung Cancer ...
COA of Capmatinib dihydrochloride hydrate | Certificate of Analysis ...
Capmatinib M18 Metabolite | CAS No- 1029713-99-2 | Simson Pharma Limited
MET inhibitor, capmatinib overcomes osimertinib resistance via ...
Capmatinib cancer drug molecule, illustration Stock Photo - Alamy
Screening of predicted compounds identifies capmatinib and other drugs ...
Capmatinib dihydrochloride (INC280 dihydrochloride) | c-MET Kinase ...
Ongoing and Future Studies with Capmatinib | Download Scientific Diagram
Current Trial Report: A Multicenter Phase I/Ib study of Capmatinib Plus ...
Inhibition of c-Met by capmatinib enhances the sensitivity of ...
Pharmacokinetics of capmatinib in participants with hepatic impairment ...
Figure 1 from The Development and Role of Capmatinib in the Treatment ...
Capmatinib in MET Exon 14 Skipping Mutation-Positive Lung Adenocarcino ...
Capmatinib for MET Exon 14-Mutated NSCLC
A Phase II Study of Capmatinib in Patients with MET-Altered Lung Cancer ...
Capmatinib | CAS No- 1029712-80-8 | NA
Capmatinib efficacy for METex14 non-small cell lung cancer patients ...
Efficacy of capmatinib in MET exon 14 skipping mutation positive ...
Demographics and characteristics of patients prior to capmatinib ...
Capmatinib (INCB28060) | 购买c-Met 抑制剂 - Selleck
Capmatinib Hydrochloride | CAS No- 1029714-89-3
HPLC with Fluorescence and Photodiode Array Detection for Quantifying ...
Capmatinib: Thuốc điều trị ung thư phổi không tế bào nhỏ
Use Existing Drugs to Treat Cancers | BenchChem
Chemical structure of capmatinib; the asterisk (*) represents the ...
Capmatinib|Tabrecta®|86|2022 | PZ – Pharmazeutische Zeitung
Tabrecta (Capmatinib) Approved for Patients with Metastatic NSCLC and ...
(PDF) Capmatinib‑associated interstitial lung disease in a patient with ...
Capmatinib(1029712-80-8) 1H NMR spectrum
Capmatinib卡马替尼-met14外显子跳跃突变靶向药 - 知乎
Safety of Tepotinib Challenge after Capmatinib-Induced Pneumonitis in a ...
Early-stage studies on capmatinib. | Download Scientific Diagram
Current key ongoing studies involving capmatinib. | Download Scientific ...
Incyte Gears Up to Report Q1 Earnings: What Can Investors Expect? - The ...
00441-8/asset/2e3557a0-670f-4cb9-bde1-bbabbb36feb8/main.assets/gr1_lrg.jpg)
00441-8/asset/f1a34a60-5b2c-4896-91b1-bb7bd6399a76/main.assets/gr3_lrg.jpg)
00441-8/asset/c3c073e0-8da8-4f31-9649-be51ae42be0f/main.assets/gr3_lrg.jpg)
00441-8/asset/957633a2-b3dd-46a7-a7ae-e5b637195a70/main.assets/gr2_lrg.jpg)
